This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Daewoong Pharmaceutical Co., Ltd., Samsung Electronics Ltd.. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 77 
1 out of 6,542 Years Active: 2013-2026
Title: Eunkyung Park: Innovator in Pharmaceutical Chemistry
Introduction
Eunkyung Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzoxazine benzimidazole derivatives.
Latest Patents
Eunkyung Park holds a patent for a benzoxazine benzimidazole derivative, which is a pharmaceutical composition that serves as an antagonist against the vanilloid receptor-1. This invention is particularly relevant for its potential use in preventing or treating diseases associated with the antagonistic activity of vanilloid receptor-1. The patent highlights the novel formula and its applications in medical science.
Career Highlights
Eunkyung Park is currently employed at Daewoong Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is instrumental in the creation of new therapeutic agents that can improve patient outcomes.
Collaborations
Eunkyung Park collaborates with esteemed colleagues such as Ji Duck Kim and Hong-Chul Yoon, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Eunkyung Park's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work on benzoxazine benzimidazole derivatives showcases the potential for new treatments that can address significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile